Senzime AB (OSTO:SEZI) Cyclically Adjusted PS Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:SEZI Senzime AB OSTO:SEZI
59 GF Score
Price kr2.90
GF Value kr10.60
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Senzime AB Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Senzime AB  (OSTO:SEZI) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Senzime AB Cyclically Adjusted PS Ratio Related Terms


Senzime AB Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Senzime AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senzime AB Cyclically Adjusted PS Ratio Chart

Senzime AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 274.24 96.30 52.70 29.89 21.26

Senzime AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.05 23.81 18.95 13.94 13.62

OSTO:SEZI vs ABT, SYK, MDT: Cyclically Adjusted PS Ratio Comparison

For the Medical Devices subindustry, Senzime AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senzime AB Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senzime AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Senzime AB's Cyclically Adjusted PS Ratio falls into.


OSTO:SEZI
59GF Score
Senzime AB OSTO:SEZI
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Senzime AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Senzime AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Senzime AB's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.157/134.6100*134.6100
=0.157

Current CPI (Jun. 2026) = 134.6100.

Senzime AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.027 101.138 0.036
201612 0.005 102.022 0.007
201703 0.000 102.022 0.000
201706 0.004 102.752 0.005
201709 0.000 103.279 0.000
201712 0.000 103.793 0.000
201803 0.000 103.962 0.000
201806 0.008 104.875 0.010
201809 0.003 105.679 0.004
201812 0.058 105.912 0.074
201903 0.008 105.886 0.010
201906 0.024 106.742 0.030
201909 0.048 107.214 0.060
201912 0.051 107.766 0.064
202003 0.049 106.563 0.062
202006 0.020 107.498 0.025
202009 0.036 107.635 0.045
202012 0.059 108.296 0.073
202103 0.023 108.360 0.029
202106 0.069 108.928 0.085
202109 0.023 110.338 0.028
202112 0.059 112.486 0.071
202203 0.037 114.825 0.043
202206 0.052 118.384 0.059
202209 0.053 122.296 0.058
202212 0.064 126.365 0.068
202303 0.100 127.042 0.106
202306 0.102 129.407 0.106
202309 0.100 130.224 0.103
202312 0.091 131.912 0.093
202403 0.101 132.205 0.103
202406 0.125 132.716 0.127
202409 0.145 132.304 0.148
202412 0.108 132.987 0.109
202503 0.176 132.825 0.178
202506 0.183 133.699 0.184
202509 0.168 133.480 0.169
202512 0.180 133.380 0.182
202603 0.148 133.550 0.149
202606 0.157 134.610 0.157

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Senzime AB (OSTO:SEZI) Overvalued in 2026?

Based on GuruFocus' analysis, Senzime AB stock appears to be undervalued. The current stock price of kr2.90 is trading 72.6% below its estimated GF Value™ of kr10.60. GuruFocus considers Senzime AB to be Possible Value Trap.

Key valuation signals for OSTO:SEZI:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: kr10.60 vs. price of kr2.90 (72.6% below fair value)
  • GF Score™: 59/100 with 3 warning signs

No single metric tells the full story. See the OSTO:SEZI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Senzime AB Business Description

Other Exchanges SNZZF:USA6YC:Germany
Address Verkstadsgatan 8, hus 1, Uppsala, SWE, 753 23
Senzime AB is a medical device company developing precision-based patient monitoring solutions for patients undergoing anesthesia. The company develops and markets precision-based monitoring systems for monitoring neuromuscular function and respiration during and after surgery, as well as for intensive care. Its product portfolio includes Next-generation TetraGraph, TetraGraph connectivity, TetraGraph for pediatric, Classic TetraGraph, and ExSpiron. The TetraGraph system is used in thousands of operating rooms internationally in university hospitals, public, private, military, and veterans hospitals. Senzime has direct sales resources in the USA and Germany and collaborates with distributors and licensees in its other main markets.
59GF Score

Get the complete analysis for OSTO:SEZI

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.90
Price
kr10.60
GF Value